Maybe it should be put out there that MSA is a type of Parkinson's. Although unlike the big Parkinson's market, which has some effective treatments, there is nothing for MSA Parkinson's. Nothing but a relentless progression to a nasty end. I recall the possible market size of around $1B. Current market cap of $21m. If the 201 trial is successful enough to predict an approvable drug, all the elements are there for this to go berserk at some stage.
Also this being a terminal disease, with not even an approved drug to slow progression, there could be pressure to bring this to market fast.
I believe early stage was chosen because it has a much better chance of success than the late stage results just revealed, which were ok imo.
DYOR
.
Maybe it should be put out there that MSA is a type of...
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
-0.001(25.0%) |
Mkt cap ! $15.96M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.3¢ | $32.63K | 10.83M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 28 | 21801548 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 130971725 | 28 |
View Market Depth
| Last trade - 16.10pm 03/10/2024 (20 minute delay) ? |
| ATH (ASX) Chart |